2025-07-08 - Analysis Report
Okay, here's a report based on the provided data, formatted as requested:

## Hims & Hers Health Inc (HIMS) Stock Analysis

**Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions direct to consumers.

### 1.  Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 181.27%
*   **VOO Cumulative Return:** 64.73%
*   **Absolute Deviation:** 193.7
*   **Relative Deviation:** 74.8

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) based on cumulative returns. The relative deviation of 74.8 suggests that HIMS's outperformance is positioned high within its historical range of deviation from the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2019-2021  | -46.0%  | 51.0% | -84.0%  | -0.0   | 1.5    |
| 2020-2022  | -15.0%  | 72.1% | -17.0%  | -0.0   | 1.4    |
| 2021-2023  | -51.0%  | 72.1% | -69.0%  | -0.1   | 2.0    |
| 2022-2024  | 127.0%  | 78.4% | 101.0%  | -0.1   | 5.5    |
| 2023-2025  | 176.0%  | 78.4% | 128.0%  | -0.1   | 10.8   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows a shift from negative growth in earlier periods to significant positive growth in recent periods (2022-2024 and 2023-2025).
*   **MDD:** The Maximum Drawdown (MDD) indicates substantial risk, with MDD values ranging from 51.0% to 78.4%.
*   **Alpha:** Alpha is largely negative in the earlier periods, indicating underperformance relative to the benchmark. However, it turns strongly positive in the recent periods (2022-2024 and 2023-2025), indicating significant outperformance.
*   **Beta:** The Beta values are consistently negative and close to zero, suggesting a low correlation with the overall market.
*   **Cap(B):** The Market Capitalization has grown significantly, from $1.5 billion to $10.8 billion, reflecting the company's growth.

### 2. Recent Stock Price Movements

*   **Current Price:** $47.98
*   **Last Market Data:** {'price': 48.43, 'previousClose': 47.98, 'change': 0.94}
*   **5-Day Moving Average:** 48.47
*   **20-Day Moving Average:** 52.54
*   **60-Day Moving Average:** 46.69

**Analysis:** The current price is slightly below the 5-day moving average and significantly below the 20-day moving average, but above the 60-day moving average. The last market data show a slight increase compared to the previous close, indicating a minor positive movement.  The price moving slightly upward could indicate a short-term upward trend or rebound.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 40.48
*   **PPO:** -1.82
*   **Hybrid Signal:** Cash_69%_Sell 1.6% of holdings (22 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** -0.7 (Negative - indicating short-term decline)
*   **Expected Return (%):** -9.3%

**Analysis:**

*   The **MRI** suggests a low-risk market environment.
*   The **RSI** of 40.48 indicates that the stock is neither overbought nor oversold, but is leaning towards the oversold side.
*   The **PPO** of -1.82 suggests that the short-term moving average is below the long-term moving average, indicating a potential downtrend.
*   The **Hybrid Signal** advises a cautious approach, recommending holding a significant cash position and selling a small portion of holdings. This advice aligns with the MRI indicating low risk.
*   The negative change in recent relative deviation confirms a short-term decline.
*   The **expected return** of -9.3% suggests underperformance relative to the S&P 500 for long-term (2+ year) investments.
*   Last-market price and change is significant and it could be a result of variable issues.

### 4. Recent News & Significant Events

*   **2025-07-06:** HIMS made headlines due to major business developments, regulatory changes, or market events.
*   **2025-07-08:** Analysts are discussing HIMS's recent performance and outlook in the context of industry trends and global economic factors.
*   **2025-07-04:** HIMS's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **2025-07-07:** Market experts highlight both risks and opportunities for HIMS, advising investors to monitor recent news and company announcements.

**Analysis:**  Recent news highlights significant events, analyst discussions, and notable volatility, emphasizing the need for investors to stay informed and closely monitor company announcements and market trends.

### 5. Recent Earnings Analysis

| Date       | EPS  | Revenue |
|------------|------|---------|
| 2025-05-05 | 0.22 | 0.59 B$ |
| 2024-11-04 | 0.35 | 0.40 B$ |
| 2024-08-05 | 0.06 | 0.32 B$ |
| 2024-05-06 | 0.05 | 0.28 B$ |
| 2025-05-05 | 0.05 | 0.28 B$ |

**Analysis:** The company's earnings per share (EPS) and revenue have shown a general upward trend, with notable increases in recent quarters. The revenue has steadily increased, indicating growing sales.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.59B  | 73.50%        |
| 2024-12-31   | $0.48B  | 76.81%        |
| 2024-09-30   | $0.40B  | 79.16%        |
| 2024-06-30   | $0.32B  | 81.30%        |
| 2024-03-31   | $0.28B  | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE     |
|--------------|---------|---------|
| 2025-03-31   | $0.55B  | 9.01%   |
| 2024-12-31   | $0.48B  | 5.46%   |
| 2024-09-30   | $0.44B  | 17.18%  |
| 2024-06-30   | $0.36B  | 3.67%   |
| 2024-03-31   | $0.34B  | 3.23%   |

**Analysis:**

*   **Revenue:** Revenue has increased steadily over the past quarters, indicating growth in the company's sales.
*   **Profit Margin:** Profit margins have generally decreased, potentially due to increased costs associated with growth or changes in pricing strategies.
*   **Equity:** Equity has increased, suggesting the company is building its asset base.
*   **ROE:** Return on Equity (ROE) has fluctuated, with a peak in 2024-09-30, but has generally remained positive, indicating profitability in relation to equity.

### 7. Overall Assessment

Hims & Hers Health Inc. (HIMS) has shown strong outperformance compared to the S&P 500, with significant growth in revenue and recent improvements in EPS. The company's market capitalization has increased substantially, reflecting investor confidence. However, recent technical indicators suggest a potential short-term downtrend, with a negative expected return relative to the S&P 500 for long-term investments.

The recent news highlights volatility and the need for investors to stay informed. The decreasing profit margins and fluctuating ROE warrant monitoring.  The recommendation from the Hybrid Signal to hold a high cash position suggests a cautious approach. Overall, while HIMS has demonstrated strong growth potential, investors should be aware of the short-term risks and potential volatility.
